|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/42 | |
| C07D 401/12 | |||
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Number of the document | 2675794 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12705384.1 |
| Date of filing the European patent application | 2012-02-17 | |
| (97) | Date of publication of the European application | 2013-12-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2012/000176 |
| Date | 2012-02-17 |
| (87) | Number | WO 2012/110774 |
| Date | 2012-08-23 |
| (30) | Number | Date | Country code |
| 201161443773 P | 2011-02-17 | US | |
| 201161523489 P | 2011-08-15 | US | |
| 201161579729 P | 2011-12-23 | US |
| (72) |
HOLMES, Ian, Peter, AU
BERGMAN, Ylva, AU
LUNNISS, Gillian Elizabeth, AU
NIKAC, Marica, AU
CHOI, Neil, AU
HEMLEY, Catherine Fae, AU
WALKER, Scott Raymond, AU
FOITZIK, Richard Charles, AU
GANAME, Danny, AU
LESSENE, Romina, AU
|
| (73) |
Cancer Therapeutics CRC Pty Limited,
4 Research Avenue, Bundoora, VIC 3083,
AU
|
| (54) | SELECTIVE FAK INHIBITORS |
| SELECTIVE FAK INHIBITORS |